Benda’s Jiangling Plant Gets Production Approval
This article was originally published in PharmAsia News
Executive Summary
SHANGHAI - Benda's Jiangling plant has received approval from China's State FDA for the production of active pharmaceutical ingredients, the company announced Jan. 22